Cefazolin

Especificaciones

25953-19-9Número CAS

247-362-8Número CE

(6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acidNombre IUPAC

C14H14N8O4S3Fórmula química

454.5 g/molPeso molecular

cefazolin; 25953-19-9; Cephazolin; Cefazoline; Cephamezine; Cefamezin; Cephazoline; Cephazolidin; Cefazolina; Cefazolinum; Elzogram; (6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; DTXSID2022753; IHS69L0Y4T; J01DB04; CHEBI:474053; DTXCID302753; (6R,7R)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; SK&F-41558; (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[2-(1H-1,2,3,4-tetrazol-1-yl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-; (6R,7R)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl)methyl)-8-oxo-7-((1H-tetrazol-1-ylacetyl)amino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl)methyl)-8-oxo-7-(2-(1H-1,2,3,4-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-3-((5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl)-8-oxo-7-((2-(tetrazol-1-yl)acetyl)amino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; RefChem:54731; 247-362-8; Cefazolin acid; CEZ; C14H14N8O4S3; Cefazina; Firmacef; Liviclina; Atirin; Acef; (6R,7R)-7-(2-(1H-tetrazol-1-yl)acetamido)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; NCGC00159465-02; Cefazoline [INN-French]; Cefazolinum [INN-Latin]; Cefazolina [INN-Spanish]; Cephamezine;Cephazoline; Cefazolin (USP); SMR000387025; CAS-25953-19-9; HSDB 3213; EINECS 247-362-8; UNII-IHS69L0Y4T; BRN 4169371; Cefazolin [USP:INN:BAN]; Cefazolin CRS; Cefazolin; (6R,7R)-3-[[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl]-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid; (6R,7R)-3-[[(5-Methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[2-(1H-tetrazol-1-yl)acetyl]amino]-5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefazolin (Standard); (6R-trans)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)-amino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; 7-(1-(1H-)-Tetrazolylacetamido)-3-(2-(5-methyl-1,3,4-thiadiazolyl)thiomethyl)delta3-cephem-4-carboxylic acid; Spectrum_000106; CEFAZOLIN [INN]; CEFAZOLIN [MI]; CEFAZOLIN [HSDB]; Prestwick0_000736; Prestwick1_000736; Prestwick2_000736; Prestwick3_000736; Spectrum2_001140; Spectrum3_000330; Spectrum4_000267; Spectrum5_000665; CEFAZOLIN [VANDF]; CEFAZOLIN [MART.]; Epitope ID:116197; EC 247-362-8; CEFAZOLIN [USP-RS]; CEFAZOLIN [WHO-DD]; SCHEMBL2841; CHEMBL1435; Lopac0_000274; BSPBio_000692; BSPBio_001939; KBioGR_000734; KBioSS_000546; MLS001032060; MLS001049010; DivK1c_000014; SPBio_001039; SPBio_002631; BPBio1_000762; orb1298974; GTPL10935; HY-B1892R; KBio1_000014; KBio2_000546; KBio2_003114; KBio2_005682; KBio3_001159; CEFAZOLIN [USP MONOGRAPH]; MSK7014; NINDS_000014; GLXC-10539; HMS2268D15; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[2-(1H-tetrazol-1-yl)acetyl]amino]-, (6R,7R)-; HY-B1892; Tox21_111691; BDBM50370587; EBC-27140; MFCD00243010; AKOS015962265; Tox21_111691_1; DB01327; SDCCGSBI-0050262.P005; IDI1_000014; NCGC00022653-09; (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-7beta-[(1H-tetrazol-1-ylacetyl)amino]-3,4-didehydrocepham-4-carboxylic acid; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)amino)-, (6R-trans)-; AC-16010; AC172185; BS-52943; Cefazolin 1000 microg/mL in Acetonitrile; SBI-0050262.P004; CS-0013954; T8390; C06880; D02299; F87674; EN300-6731073; C167200; F863147; Q415739; BRD-K99750640-236-18-7; BRD-K99750640-236-19-5; (6R, 7R)-3-[[(5-Methyl-1,3,4-thiadiazol-2- yl)thio]methyl]-8-oxo-7-[[1H-tetrazol-1- yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2- ene-2-carboxylic acid; (6R,7R)-3-[[(5-Methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[2-(1H-tetrazol-1-yl)acetamido]5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[2-(1H-tetrazol-1-yl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 3-(((5-METHYL-1,3,4-THIADIAZOL-2-YL)THIO)METHYL)-8-OXO-7-(((1H-TETRAZOL-1-YL)ACETYL)AMINO)-(6R-TRANS); 50918-36-0Sinónimos